随着我国创新药对外授权交易创新高,“出海”已成为我国生物医药在全球产业竞争格局中深度重塑、寻求新发展的重要举措。 中国生物制品质量控制大会发布的数据显示,据不完全统计,2025年上半年我国创新药对外授权(License-out)交易总金额近660亿美元,超过2024年全年的519亿美元。 面对产业发展呈现的新趋势,接下来生药企业出海路在何方? 在29日下午举行的2025上海国际生物技术与医药...
Source Link随着我国创新药对外授权交易创新高,“出海”已成为我国生物医药在全球产业竞争格局中深度重塑、寻求新发展的重要举措。 中国生物制品质量控制大会发布的数据显示,据不完全统计,2025年上半年我国创新药对外授权(License-out)交易总金额近660亿美元,超过2024年全年的519亿美元。 面对产业发展呈现的新趋势,接下来生药企业出海路在何方? 在29日下午举行的2025上海国际生物技术与医药...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.